Brian Leuthner
Founder at Alivio Therapeutics, Inc.
Net worth: - $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Elenko | M | 51 |
Alivio Therapeutics, Inc.
 Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | - |
| John LaMattina | M | 74 |
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | - |
| Robert Langer | M | 74 |
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | - |
| Ben Shapiro | M | 84 |
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | - |
| Joep Muijrers | M | 51 |
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | - |
| Stephen M. Muniz | M | - |
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | - |
| Bridget O'Keeffe | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel O'Connor | M | 59 | 4 years | |
| Howard Weisman | M | 64 |
ESP Pharma, Inc.
 ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | 3 years |
| Kim Jaffe | M | - | - | |
| Gregory C. Williams | M | 65 | 7 years | |
| Hiroaki Shigeta | M | 81 | - | |
| Melvin Spigelman | M | 75 | 13 years | |
| Fred M. Ryan | M | 72 | 5 years | |
| Elizabeth Hamilton Seabury Wyatt | M | 76 | - | |
| Andrew Einhorn | M | 64 |
ESP Pharma, Inc.
ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | 2 years |
| Steven Hubrig Koehler | M | 73 | 4 years | |
| Dennis P. Reilly | M | 65 | 3 years | |
| Bill O'Connor | M | 64 | 12 years | |
| Adair Newhall | M | 45 |
ESP Pharma, Inc.
ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | 2 years |
| Brian Andersen | M | - |
ESP Pharma, Inc.
ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | 3 years |
| John Rodriguez | M | - | - | |
| Dave Iwanicki | M | 58 |
ESP Pharma, Inc.
ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | 3 years |
| Robert J. Weiland | M | 64 | 2 years | |
| Catharine S. Newberry | F | 73 | 3 years | |
| Doug Randall | M | - | 5 years | |
| Seth Lederman | M | 66 |
Fontus Pharmaceuticals, Inc.
| 1 years |
| Ali Behbahani | M | 48 | 2 years | |
| James Edward Thomas | M | 63 | 9 years | |
| Lance Baldo | M | 51 | 5 years | |
| Kelli Watson-Pacicco | F | 62 | - | |
| Leslie C. Rohrbacker | F | 55 | 7 years | |
| Anthony A. Rascio | M | - |
ESP Pharma, Inc.
ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | - |
| Leonard Bell | M | 65 | 5 years | |
| Joe Smith | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 35 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Brian Leuthner
- Personal Network
